Lung-Directed chemo spray aims to stop cancer spread

NCT ID NCT03965234

Recruiting now Disease control Sponsor: Roswell Park Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a procedure called pulmonary suffusion, which delivers the chemotherapy drug cisplatin directly to the lungs through a minimally invasive method. The goal is to control any remaining cancer cells after surgery or ablation in patients with sarcoma or colorectal cancer that has spread to the lungs. About 99 adults with resectable or ablatable lung metastases are being enrolled to evaluate safety and effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone cancer bone osteosarcoma bone sarcoma colorectal cancer colorectal neoplasm metastatic malignant neoplasm sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER METASTATIC BONE SARCOMA METASTATIC MALIGNANT NEOPLASM IN THE LUNG METASTATIC SOFT-TISSUE SARCOMA METASTATIC UNRESECTABLE SARCOMA RESECTABLE SARCOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Roswell Park Cancer Institute
RECRUITING

Buffalo, New York, 14263, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••